⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
businesswire.com
GOSS
Pomerantz LLP Updates Investors on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 Ready to Announce with Confidence?
newsfilecorp.com
GOSS
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Pomerantz LLP Shares Class Action Details With Shareholders in Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
accessnewswire.com
GOSS
Pomerantz LLP Updates Investors on Legal Action Brought Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Pomerantz LLP Shares Class Action Details With Investors in Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman
globenewswire.com
GOSS